- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Kyle Brasseur2023-04-19T14:20:00
The New York-based investment banking division of Barclays was fined $2.5 million as part of a settlement with the Financial Industry Regulatory Authority (FINRA) addressing allegations it failed to accurately report over-the-counter (OTC) options positions in more than 4 million instances.
Barclays Capital (now Barclays Corporate and Investment Bank) failed to reasonably supervise its large options positions reporting (LOPR) system, which was hampered by four separate coding errors, according to FINRA’s settlement published Tuesday. The alleged issues resulted in 4.3 million violations of FINRA Rules 2360(b)(5) regarding options positions and 2010 on principles of trade.
The four coding errors existed over varying periods ranging four to eight years from January 2011 through December 2022, according to FINRA. They included:
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Barclays Bank disclosed an investigation by the U.K. Financial Conduct Authority into the bank’s anti-money laundering controls has closed without a penalty.
Goldman Sachs agreed to pay $425,000 as part of a settlement with the Financial Industry Regulatory Authority addressing allegations of reporting and supervision violations regarding more than 1 million over-the-counter options positions.
JPMorgan Securities agreed to pay $750,000 to settle allegations levied by the Financial Industry Regulatory Authority that its inadequate financial risk management controls and supervisory procedures allowed erroneous orders to be placed with exchanges or alternative trading systems.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
